JP2023521564A5 - - Google Patents

Info

Publication number
JP2023521564A5
JP2023521564A5 JP2022556017A JP2022556017A JP2023521564A5 JP 2023521564 A5 JP2023521564 A5 JP 2023521564A5 JP 2022556017 A JP2022556017 A JP 2022556017A JP 2022556017 A JP2022556017 A JP 2022556017A JP 2023521564 A5 JP2023521564 A5 JP 2023521564A5
Authority
JP
Japan
Application number
JP2022556017A
Other languages
Japanese (ja)
Other versions
JP2023521564A (ja
JPWO2021186053A5 (https=
Filing date
Publication date
Priority claimed from EP20305299.8A external-priority patent/EP3881844A1/en
Priority claimed from EP20305327.7A external-priority patent/EP3884946A1/en
Application filed filed Critical
Priority claimed from PCT/EP2021/057123 external-priority patent/WO2021186053A1/en
Publication of JP2023521564A publication Critical patent/JP2023521564A/ja
Publication of JP2023521564A5 publication Critical patent/JP2023521564A5/ja
Publication of JPWO2021186053A5 publication Critical patent/JPWO2021186053A5/ja
Pending legal-status Critical Current

Links

JP2022556017A 2020-03-20 2021-03-19 コロナウイルス科ウイルス感染症を処置又は予防する為の化合物及びコロナウイルス科ウイルス感染症の発生を評価する方法及び使用方法 Pending JP2023521564A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
EP20305299.8A EP3881844A1 (en) 2020-03-20 2020-03-20 Compounds for treating or preventing a coronaviridae infection & methods and uses for assessing the occurrence of a coronaviridae infection
EP20305299.8 2020-03-20
EP20305327.7A EP3884946A1 (en) 2020-03-25 2020-03-25 Compounds for treating or preventing a coronaviridae infection & methods and uses for assessing the occurrence of a coronaviridae infection
EP20305327.7 2020-03-25
EP20305482 2020-05-12
EP20305482.0 2020-05-12
EP20306483.7 2020-12-03
EP20306483 2020-12-03
PCT/EP2021/057123 WO2021186053A1 (en) 2020-03-20 2021-03-19 Compounds for treating or preventing a coronaviridae infection & methods and uses for assessing the occurrence of a coronaviridae infection

Publications (3)

Publication Number Publication Date
JP2023521564A JP2023521564A (ja) 2023-05-25
JP2023521564A5 true JP2023521564A5 (https=) 2024-03-29
JPWO2021186053A5 JPWO2021186053A5 (https=) 2024-03-29

Family

ID=74884979

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022556017A Pending JP2023521564A (ja) 2020-03-20 2021-03-19 コロナウイルス科ウイルス感染症を処置又は予防する為の化合物及びコロナウイルス科ウイルス感染症の発生を評価する方法及び使用方法

Country Status (11)

Country Link
US (1) US20230142547A1 (https=)
EP (1) EP4121053A1 (https=)
JP (1) JP2023521564A (https=)
KR (1) KR20220152292A (https=)
CN (1) CN115605205A (https=)
AU (1) AU2021238792A1 (https=)
BR (1) BR112022018793A2 (https=)
CA (1) CA3172179A1 (https=)
IL (1) IL296522A (https=)
MX (1) MX2022011596A (https=)
WO (1) WO2021186053A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023126951A1 (en) * 2022-01-03 2023-07-06 Yeda Research And Development Co. Ltd. Inhibitors of autophagy-related protein-protein interactions
CN118373771A (zh) * 2023-01-20 2024-07-23 江苏柯菲平医药股份有限公司 一种喹啉衍生化合物或其可药用的盐及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070225363A1 (en) 2003-11-21 2007-09-27 The University Of Newcastle Research Associates Ltd. Methods and Agents for Inhibiting Dynamin-Dependent Endocytosis
SI2440547T1 (sl) 2009-06-12 2023-05-31 Abivax Nove kemične molekule, ki zavirajo mehanizem spajanja za zdravljenje bolezni, ki so posledica napak pri spajanju
EP2757161A1 (en) 2013-01-17 2014-07-23 Splicos miRNA-124 as a biomarker of viral infection
EP2862928A1 (en) 2013-10-18 2015-04-22 Université de Strasbourg Dynamin 2 inhibitor for the treatment of centronuclear myopathies
EP3058940A1 (en) * 2015-02-23 2016-08-24 Abivax Quinoline derivatives for use in the treatment or prevention of viral infection
EP3059236A1 (en) * 2015-02-23 2016-08-24 Abivax A new quinoline derivative for use in the treatment and prevention of viral infections
EP3594206A1 (en) 2018-07-09 2020-01-15 Abivax Phenyl-n-quinoline derivatives for treating a rna virus infection
EP3858815A1 (en) * 2020-01-31 2021-08-04 Abivax Co-crystals and salts of 8-chloro-n-(4-(trifluoromethoxy)phenyl)quinolin-2-amine
CA3164700A1 (en) * 2020-01-31 2021-08-05 Abivax Amorphous solid dispersion of 8-chloro-n-(4-(trifluoromethoxy)phenyl)quinolin-2-amine
KR20210151949A (ko) * 2020-04-05 2021-12-14 화이자 인코포레이티드 Covid-19의 치료를 위한 화합물 및 방법

Similar Documents

Publication Publication Date Title
JP2023521564A5 (https=)
JPWO2022249486A1 (https=)
CN305605937S (https=)
CN305608762S (https=)
CN305535643S (https=)
CN305533749S (https=)
CN305533210S (https=)
CN305532924S (https=)
CN305532201S (https=)
CN305531828S (https=)
CN305530366S (https=)
CN305530334S (https=)
CN305530161S (https=)
CN305529149S (https=)
CN305528846S (https=)
CN305527363S (https=)
CN306536456S (https=)
CN306306881S (https=)
CN305831883S (https=)
CN305827636S (https=)
CN305619115S (https=)
CN305618025S (https=)
CN305617717S (https=)
CN305616833S (https=)
CN305616638S (https=)